PIM kinase inhibition: co-targeted therapeutic approaches in prostate cancer. [electronic resource]
Producer: 20211007Description: 7 p. digitalISSN:- 2059-3635
- Apoptosis -- drug effects
- Drug Resistance, Neoplasm -- genetics
- Humans
- Male
- Molecular Targeted Therapy
- Phosphatidylinositol 3-Kinases -- genetics
- Prostatic Neoplasms -- drug therapy
- Protein Kinase Inhibitors -- therapeutic use
- Proto-Oncogene Proteins c-akt -- genetics
- Proto-Oncogene Proteins c-pim-1 -- antagonists & inhibitors
- TOR Serine-Threonine Kinases -- genetics
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
There are no comments on this title.
Log in to your account to post a comment.